To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients

Summary

4week, a Multicenter, Randomized, Double-blinded, Parallel, Therapeutic confirmatory Clinical Trial

Timeline

Start

2017-02-07

Primary completion

2017-02-20

Completion

2017-10-16

Drugs

Indications